Eliem Therapeutics Inc

NASDAQ ELYM

Data sourced from iex and EODHD
Download Data

Eliem Therapeutics Inc Income Statement 2020 - 2024

This table shows the Income Statement for Eliem Therapeutics Inc going from 2020 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Cost of Revenue
M - - - - - - - - - - - - - - - - -
Gross Profit
M - - - - - - - - - - - - - - - - -
Operating Expenses
M - - - - - - - - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 2 2 2 3 18 5 4 5 5 4 3 3 2 2 0 0 0
Research and Development (R&D) Expenses
M 1 3 3 4 6 5 4 9 8 7 6 6 5 4 2 1 2
Other Operating Expenses
M - - - - - - - - - - - - - - - - -
Costs and Expenses
M - - - - - - - - - - - - - - - - -
Operating Income
M -3 -5 -5 -7 -23 -10 -9 -14 -13 -11 -9 -9 -7 -15 -2 -2 -2
Interest Expense
M - 1 - - -1 3 2 2 0 - - - - - - - -
Non-operating Income/Expense
M 1 1 1 1 1 2 -1 -1 0 0 0 0 -12 -9 0 0 0
EBT
M -2 -4 -4 -5 -22 -8 -10 -15 -13 -11 -10 -9 -19 -15 -2 -2 -2
Income Tax Provision
M -3 0 0 - -1 -2 1 1 0 0 10 - - -9 - - -
Income after Tax
M 1 -4 -4 - -21 -6 -11 -15 -13 -10 -19 - - -6 - - -
Non-Controlling Interest
M - - - 0 0 0 0 0 -14 -9 -8 2 1 - 0 0 -
Net Income
M - - - -5 -22 -8 -10 -15 -13 -1 -11 -11 -20 - -3 -2 -2
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 27,638,528.00 27,699,446.00 27,071,053.00 26,840,555.00 26,492,438.00 26,372,935.00 26,336,029.00 26,296,560.00 26,238,950.00 26,225,842.00 15,585,611.00 23,458,226.00 11,661,662.00 11,661,662.00 11,661,662.00 11,661,662.00 11,661,662.00
EBITDA
M -3 -5 -5 -7 -23 -11 -7 -13 -13 -11 -9 -9 -7 3 -2 -2 -2
Depreciation and Amortization
M 3 0 0 0 0 -1 1 1 0 0 0 0 0 18 0 0 0
EBIT
M -6 -5 -5 -7 -23 -10 -9 -14 -13 -11 -9 -9 -7 -15 -2 -2 -2
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% 177.08 0.08 0.12 - 5.15 23.09 -9.65 -6.13 -0.55 4.44 -100.19 - - 61.62 - - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 - 0 0 0
Gross Profit Margin
% - - - - - - - - - - - - - - - - -
Operating Income Margin
% - - - - - - - - - - - - - - - - -
Net Income Margin
% - - - - - - - - - - - - - - - - -
EBITDA Ratio
% - - - - - - - - - - - - - - - - -
EBIT Ratio
% - - - - - - - - - - - - - - - - -
EBT Ratio
% - - - - - - - - - - - - - - - - -

StockViz Staff

September 16, 2024

Any question? Send us an email